secwatch.observer — SEC 8-K summary
======================================

Issuer:     DANAHER CORP /DE/ (DHR)
CIK:        0000313616
Form:       8-K
Filed at:   2026-02-17T23:59:59+00:00
Accession:  0001193125-26-053124
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 8.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Danaher to acquire Masimo for $180/share cash, ~$9.9B enterprise value
----------------------------------------------------------------------

- All-cash deal at $180/share; total enterprise value ~$9.9B including assumed debt.
- Represents ~18x estimated 2027 EBITDA, or 15x including full annual synergies.
- Masimo to operate as standalone company within Danaher's Diagnostics segment.
- Expected to close H2 2026; subject to Masimo shareholder and regulatory approvals.
- Expects $125M annual cost synergies and >$50M revenue synergies by year 5; EPS accretive $0.15–0.20 first year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313616/000119312526053124/0001193125-26-053124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313616/000119312526053124/d110495d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-053124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer